Therapy

Why?

• Patients on low-molecular weight heparin for 6 months are less likely to die from heart disease, reinfarct or develop angina. ^a

LMWH reduces death, reinfarction and angina

Patient	Treatment	Comparison	Outcome	CER	RRR (95% CI)	NNT (95% CI)
myocardial infarction a	clexane	no therapy	MI, angina or cardiac death at 6 months	45%	69% (31% to 86%)	3 (2 to 7)